Search results
ITCI stock rated an Outperform by Robert W. Baird – Knox Daily
Knox Daily· 15 hours agoRobert W. Baird initiated its Intra-Cellular Therapies Inc [ITCI] rating to an Outperform in a research note published on January 03, 2024; the price target ...
Curbing the price of novel diabetes and obesity medications
Medical Xpress· 5 hours agoThe implications of exorbitant prices for these novel therapies are alarming, according to Lipska, who first became aware of the drug pricing issue in 2016 when one of her patients couldn't ...
Weight loss drugs like Wegovy have taken the country by storm. But who can afford them?
USA TODAY· 4 days agoPatients like Price are struggling to afford a blockbuster class of weight-loss medications called...
Intra-Cellular Therapies (NASDAQ:ITCI) Given New $107.00 Price Target at Canaccord Genuity Group
ETF DAILY NEWS· 6 days agoIntra-Cellular Therapies (NASDAQ:ITCI – Free Report) had its target price increased by Canaccord Genuity Group from $100.00 to $107.00 in a research note
Insider Selling: Mates Sharon, Intra-Cellular Therapies Inc [ITCI] Chairman, President & CEO...
Knox Daily· 5 days agoUpon closing the transaction, the insider’s holdings decreased to 7,345 shares, worth approximately $0.0. As published in their initiating research note from Robert W. Baird ...
The 56 Best Gifts for Wives Who Have Everything to Receive This Mother’s Day
WWD via Yahoo News· 1 hour agoSurprise her with HigherDose’s Red Light Neck Enhancer. The LED light therapy mask encourages...
What consumers should know as Philips agrees to $1.1 billion CPAP settlement
NPR· 3 hours agoPhilips announced the new settlement on Monday, along with its first-quarter financial results. The...
Apple upgraded, Tesla downgraded: Wall Street's top analyst calls
The Fly via Yahoo Finance· 9 hours agoGuggenheim also started coverage of Abivax with a Buy rating and $50 price target. Leerink initiated...
NKGen Biotech gears up for Parkinson's trial after FDA nod By Investing.com
Investing.com· 2 hours agoFood and Drug Administration (FDA) to proceed with its Investigational New Drug (IND) application...
Deciphera Catapults 73% On Ono Pharmaceutical's $2.4 Billion Takeover
Investor's Business Daily· 2 hours agoThe deal places a fair value on Deciphera stock, he said. He had a 23 price target on shares, while...